Chrono Therapeutics was founded to transform disease and addiction management using wearable, patient-optimized drug delivery devices. With real-time wireless connectivity and tailored behavioral support, Chrono's science of specifically tailoring the timing and dose sizes of drugs preempts predictable peak disease or addiction symptoms with an easy-to-use device. Chrono has built a pipeline of pharmaceutical applications that have potential to better manage common conditions and diseases with 'smart' drug delivery and behavioral support technologies.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/13/14 | $32,000,000 | Series A |
5AM Ventures Canaan Partners Fountain Healthcare Partners GE Ventures Mayo Clinic | undisclosed |
